SCHEMBL670704

SCHEMBL670704

CS(=O)(=O)c1ccccc1[O]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.41
KEAP1 Q14145 1/20 0.41
LOX P28300 1/20 0.38
GAA P10253 1/20 0.37
DRD2 P14416 1/20 0.37
HSD11B1 P28845 1/20 0.37
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA12 O43570 1/20 0.36
CYP2C9 P11712 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
PTGS2 P35354 1/20 0.35
NR3C2 P08235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8106699 0.83 LOX (0.47) BCAT2KEAP1LOXGAADRD2
SCHEMBL10887594 0.78 GAA (0.52) KEAP1GAACA1CA2CA4
SCHEMBL942877 0.75 G6PD (0.39) BCAT2LOXGAADRD2HSD11B1
SCHEMBL2645595 0.75 PSIP1 (0.50) GAAHSD11B1CA1CA2CA4
SCHEMBL12307 0.74 L3MBTL1 (0.50) BCAT2HSD11B1L3MBTL1ALDH1A1TP53
SCHEMBL28278788 0.74 L3MBTL1 (0.50) BCAT2HSD11B1L3MBTL1ALDH1A1TP53
SCHEMBL1808913 0.74 CA2 (0.58) GAACA1CA2CA4CA6
SCHEMBL1373436 0.74 TSHR (0.46) GAACA1CA2CA4CA6
SCHEMBL11757324 0.73 PSIP1 (0.39) KEAP1LOXGAAHSD11B1CA1
SCHEMBL7420444 0.73 DRD2 (0.35) BCAT2LOXGAADRD2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102558149-A Pyrimidine derivative, preparation method thereof, medicinal composition and application thereof INST MATERIA MEDICA CAMS 2012-07-11 CN claimed
JP-2010536773-A 2010-12-02 JP claimed
EP-2185570-A2 NOVEL ACTIVATORS OF GLUCOKINASE Metabasis Therapeutics, Inc. (US) 2010-05-19 EP claimed
WO-2009023718-A2 NOVEL ACTIVATORS OF GLUCOKINASE METABASIS THERAPEUTICS, INC. (US) 2009-02-19 WO claimed
CN-101039901-A Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2007-09-19 CN claimed
US-6369247-B1 OXIDATION WITH HYDROPEROXIDE IN THE PRESENCE OF RUTHENIUM CATALYST MERCK & CO., INC. 2002-04-09 US claimed
EP-0759929-B1 OXIDATION OF STEROIDS HAVING ALLYLIC GROUPS MERCK & CO INC (US) 2000-08-23 EP claimed
EP-0858455-A4 4-OXA AND 4-THIA STEROIDS MERCK & CO INC (US) 2000-04-12 EP claimed
US-5998464-A 4-Oxa and 4-thia steroids MERCK & CO., INC. (US) 1999-12-07 US claimed
US-5817802-A IN IONIZING MEDIUM WITH A TRIALKYLSILANE MERCK & CO., INC. (US) 1998-10-06 US claimed
EP-0759929-A4 OXIDATION OF STEROIDS HAVING ALLYLIC GROUPS MERCK & CO INC (US) 1998-09-30 EP claimed
EP-0858455-A1 4-OXA AND 4-THIA STEROIDS Merck & Co., Inc. (US) 1998-08-19 EP claimed
US-5777134-A 4-oxa and 4-thia steriods MERCK & CO., INC. (US) 1998-07-07 US claimed
US-5696266-A HYDROGENATING DELTA-5-STEROIDAL ENELACTAM DISSOLVED IN SOLVENT IN PRESENCE OF RHODIUM CATALYST MERCK & CO., INC. (US) 1997-12-09 US claimed
WO-1997015564-A1 4-OXA AND 4-THIA STEROIDS MERCK & CO., INC. (US) 1997-05-01 WO claimed
EP-0759929-A1 OXIDATION OF STEROIDS HAVING ALLYLIC GROUPS Merck & Co., Inc. (a New Jersey corp.) (US) 1997-03-05 EP claimed
CN-1130391-A Dye mixtures containing azo dyes having the same colour and coupling component from diaminopyridine series BASF AG (DE) 1996-09-04 CN claimed
WO-1996007643-A1 PROCESS FOR THE STEREOSELECTIVE REDUCTION OF STEROID ENELACTAMS MERCK & CO., INC. (US) 1996-03-14 WO claimed
WO-1995032215-A1 OXIDATION OF STEROIDS HAVING ALLYLIC GROUPS MERCK & CO., INC. (US) 1995-11-30 WO claimed
CN-1083477-A 4-imino-quinoline, its preparation method and application thereof HOECHST AG (DE) 1994-03-09 CN claimed